ITUB Volume Alert - ITUB 14.10 Itau Unibanco Banco Holding

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
ITUB Volume Alert - ITUB 14.10 Itau Unibanco Banco Holding Sa $ITUB Hit a high of 14.12 Currently 11/07/14 Last price 14.10 +0.26 +1.88% With a day low of 13.84 and a current volume of 8,935,900.

ITUB Itau Unibanco Banco Holding Sa Recent Headline News

Quarterly Financial Results, New Service Launch, and Appointments - Research Reports on Eastman Chemical, American Express, Itau Unibanco, Marsh & McLennan and ACE
PR Newswire - Fri Nov 07, 7:40AM CST
Today, Analysts Review released its research reports regarding Eastman Chemical Co. (NYSE: EMN), American Express Company (NYSE: AXP), Itau Unibanco Holding S.A. (NYSE: ITUB), Marsh & McLennan Companies, Inc. (NYSE: MMC) and ACE Limited (NYSE: ACE). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7773-100free.
ACE: 110.81 (+0.08), AXP: 92.26 (+0.68), EMN: 82.47 (+0.01), ITUB: 14.10 (+0.26), MMC: 55.80 (-0.07)

After Yesterday's Decline of 5.14%, Itau Unibanco Holding SA Offers Investors Better Value
Comtex SmarTrend(R) - Thu Nov 06, 4:43PM CST
Itau Unibanco Holding SA (NYSE:ITUB) traded in a range yesterday that spanned from a low of $13.75 to a high of $14.28. Yesterday, the shares fell 5.1%, which took the trading range below the 3-day low of $14.25 on volume of 10.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ITUB: 14.10 (+0.26)

Itau Unibanco (ITUB) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Wed Nov 05, 7:05PM CST
The following Itau Unibanco (ITUB) conference call took place on November 5, 2014, 09:00 AM ET. This is a transcript of that earnings call:
ITUB: 14.10 (+0.26)

Royal Bank of Scotland's $275M Settlement Finally Approved - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 5:33PM CST
Edinburgh, U.K.-based The Royal Bank of Scotland Group plc (RBS) received final approval from Judge Loretta A. Preska, of the U.S. District Court for the Southern District of New York, for a $275 million cash settlement of a U.S. lawsuit.
BMO: 71.72 (+0.38), RBS: 11.90 (-0.16), CM: 90.98 (+0.50), ITUB: 14.10 (+0.26)

Itau Unibanco Posts Solid Q3 Earnings on High Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 9:50AM CST
Driven by strong top-line performance, Brazil's Itau Unibanco Holding S.A. (ITUB) reported third-quarter 2014 recurring earnings of R$5.5 billion ($2.42 billion), up 37.5% year over year.
DB: 30.24 (-0.38), RBS: 11.90 (-0.16), UBS: 17.06 (-0.04), ITUB: 14.10 (+0.26)

Royal Bank of Scotland Posts Solid Q3 Earnings; Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 9:40AM CST
The Royal Bank of Scotland Group plc's (RBS) share price jumped 5.9% to $12.43, following the impressive earnings for third-quarter 2014. Profit attributable to shareholders came in at ??896 million ($1.5 billion) compared with loss of ??828 million ($1.28 billion) in the prior-year comparable period.
MTU: 5.46 (unch), RY: 71.50 (+0.55), RBS: 11.90 (-0.16), ITUB: 14.10 (+0.26)

Follow our conference call: 2014 - 3rd Quarter Results - Itau Unibanco Holding S.A.
PR Newswire - Mon Nov 03, 8:30AM CST
Itau Unibanco Holding S.A. (BM&FBovespa: ITUB4 and ITUB3; NYSE: ITUB and BCBA: ITUB4) is pleased to invite you to participate in our conference calls about the 2014 - 3rd quarter results.
ITUB: 14.10 (+0.26)

Barclays PLC (BCS) Jumps: Stock Gains 7.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:04AM CST
Barclays PLC (BCS) was a big mover last session, as the company saw its shares rise over 7% on the day.
BCS: 14.91 (-0.10), RBS: 11.90 (-0.16), ITUB: 14.10 (+0.26), BNS: 59.54 (+0.77)

Will HSBC's Earnings Disappoint on Muted Revenue Growth? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 5:33PM CDT
Will HSBC be able to reverse the trend this time or will it again succumb to the tough industry backdrop? Let's see what factors might have influenced the earnings.
TD: 49.22 (+0.34), RY: 71.50 (+0.55), HSBC: 50.09 (-0.27), ITUB: 14.10 (+0.26)

Will Royal Bank of Scotland Q3 Earnings Impress This Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 5:23PM CDT
The Royal Bank of Scotland Group plc (RBS) is scheduled to report its third-quarter 2014 results on Friday, Oct 31.
RY: 71.50 (+0.55), HSBC: 50.09 (-0.27), RBS: 11.90 (-0.16), ITUB: 14.10 (+0.26)

Deutsche Bank (DB) Posts Loss in Q3 on Litigation Issues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 9:10AM CDT
Deutsche Bank AG (DB) reported net loss of ???92 million ($122 million) in the third quarter of 2014, compared with income of ???51 million ($67.5 million) in the prior-year quarter.
HSBC: 50.09 (-0.27), DB: 30.24 (-0.38), UBS: 17.06 (-0.04), ITUB: 14.10 (+0.26)

Upcoming Conferences, Quarterly Dividend, Earnings, and Recognition - Research Reports on JPMorgan Chase, Bank of America, Citigroup, Wells Fargo and Itau Unibanco
PR Newswire - Wed Oct 29, 7:40AM CDT
Today, Analysts Review released its research reports regarding JPMorgan Chase & Co. (NYSE: JPM), Bank of America Corporation (NYSE: BAC), Citigroup Inc. (NYSE: C), Wells Fargo & Company (NYSE: WFC) and Itau Unibanco Holding S.A. (NYSE: ITUB). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7521-100free.
JPM: 61.47 (+0.24), C: 53.75 (-0.24), WFC: 53.84 (-0.22), BAC: 17.36 (unch), ITUB: 14.10 (+0.26)

Itau Unibanco (ITUB) Stock Recovers Following Brazilian President Dilma Rousseff's Re-Election
at The Street - Tue Oct 28, 2:06PM CDT
Shares of Itau Unibanco (ITUB) surged in afternoon trading Tuesday after the stock plummeted Monday following Brazilian President Dilma Rousseff's re-election on Sunday.
ITUB: 14.10 (+0.26)

UBS AG Posts Strong Q3 Earnings on Higher Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 10:10AM CDT
UBS AG (UBS) reported third-quarter 2014 net income attributable to shareholders of CHF 762 million ($834.2 million), which compared favorably with the prior-year quarter earnings of CHF 577 million ($619.1 million).
RY: 71.50 (+0.55), HSBC: 50.09 (-0.27), UBS: 17.06 (-0.04), ITUB: 14.10 (+0.26)

Will Deutsche Bank AG (DB) Disappoint Again This Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 5:12PM CDT
Deutsche Bank AG (DB) is scheduled to report its third-quarter 2014 results on Wednesday, Oct 29.
RY: 71.50 (+0.55), HSBC: 50.09 (-0.27), DB: 30.24 (-0.38), ITUB: 14.10 (+0.26)

Look for Shares of Itau Unibanco Holding SA to Potentially Rebound after Yesterday's 4.67% Sell Off
Comtex SmarTrend(R) - Mon Oct 27, 3:48PM CDT
Itau Unibanco Holding SA (NYSE:ITUB) traded in a range yesterday that spanned from a low of $12.43 to a high of $12.91. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $12.71 on volume of 41.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ITUB: 14.10 (+0.26)

Itau Unibanco (ITUB) Stock Down Today Following Brazil Presidential Election Results
at The Street - Mon Oct 27, 9:37AM CDT
Itau Unibanco (ITUB) is falling Monday after Brazilian president Dilma Rousseff was elected to a second term.
BBD: 14.10 (+0.08), VALE: 9.43 (+0.29), ITUB: 14.10 (+0.26)

Petrobras, Brazil Stocks Dive On Rousseff Re-Election
at Investor's Business Daily - Mon Oct 27, 9:32AM CDT
Petrobras (PBR) and other Brazilian stocks plunged Monday after leftist President Dilma Rousseff was re-elected Sunday. Rousseff narrowly won re-election over center-right and pro-business candidate Aecio Neves, with 51.6%. Neves won many of the more...
PBR: 10.90 (+0.17), TSU: 25.92 (+0.08), BBD: 14.10 (+0.08), VALE: 9.43 (+0.29), EWZ: 40.98 (+0.60), ITUB: 14.10 (+0.26)

Stock Futures Point Lower; Brazil Vote Hammers Petrobras
at Investor's Business Daily - Mon Oct 27, 8:05AM CDT
Stock futures showed moderate losses ahead of Monday's open. Dow futures were 40.4 points below fair market value and dropping. Nasdaq 100 futures were off a mild 5.6 points. S&P 500 futures slipped 5.4 points. The stock market today opens the week...
AGN: 196.00 (-1.40), PBR: 10.90 (+0.17), VRX: 126.11 (-2.66), TSU: 25.92 (+0.08), BBD: 14.10 (+0.08), MRK: 59.34 (+0.08), KLAC: 80.00 (-0.83), ITUB: 14.10 (+0.26)

Is UBS AG (UBS) Likely to Disappoint Earnings this Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 2:55PM CDT
UBS AG (UBS) is scheduled to report its third-quarter 2014 results on Tuesday, Oct 28.
RY: 71.50 (+0.55), HSBC: 50.09 (-0.27), UBS: 17.06 (-0.04), ITUB: 14.10 (+0.26)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading